{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:11:19Z","timestamp":1785298279477,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,10,13]],"date-time":"2007-10-13T00:00:00Z","timestamp":1192233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s11481-007-9092-0","type":"journal-article","created":{"date-parts":[[2007,10,12]],"date-time":"2007-10-12T14:26:55Z","timestamp":1192199215000},"page":"95-104","source":"Crossref","is-referenced-by-count":56,"title":["Antiretroviral Treatment is Associated with Increased Attentional Load-Dependent Brain Activation in HIV Patients"],"prefix":"10.1007","volume":"3","author":[{"given":"L.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yakupov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,13]]},"reference":[{"key":"9092_CR1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jneuroim.2004.08.025","volume":"157","author":"MJ Avison","year":"2004","unstructured":"Avison MJ, Nath A, Greene-Avison R, Schmitt FA, Greenberg RN, Berger JR (2004) Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol 157:140\u20136","journal-title":"J Neuroimmunol"},{"key":"9092_CR2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/13803390490510031","volume":"26","author":"CL Carey","year":"2004","unstructured":"Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I et al (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307\u2013319","journal-title":"J Clin Exp Neuropsychol"},{"key":"9092_CR3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1212\/WNL.53.4.782","volume":"53","author":"L Chang","year":"1999","unstructured":"Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I et al (1999) Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 53:782\u2013789","journal-title":"Neurology"},{"key":"9092_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/135965350300800103","volume":"8","author":"L Chang","year":"2003","unstructured":"Chang L, Ernst T, Witt M, Ames N, Walot I, Jovicich J et al (2003) Persistent brain abnormalities in antiretroviral-na\u00efve HIV patients three-months after HAART. Antivir Ther 8:17\u201326","journal-title":"Antivir Ther"},{"key":"9092_CR5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1212\/WNL.57.6.1001","volume":"57","author":"L Chang","year":"2001","unstructured":"Chang L, Speck O, Miller E, Braun A, Jovicich J, Koch C et al (2001) Neural correlates of attention and working memory deficits in HIV patients. Neurology 57:1001\u20131007","journal-title":"Neurology"},{"key":"9092_CR6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.20190","volume":"56","author":"L Chang","year":"2004","unstructured":"Chang L, Tomasi D, Yakupov R, Lozar C, Arnold S, Caparelli E et al (2004) Adaptation of the attention network in human immunodeficiency virus brain injury. Ann Neurol 56:259\u2013272","journal-title":"Ann Neurol"},{"key":"9092_CR7","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1152\/jn.1998.80.5.2657","volume":"80","author":"JC Culham","year":"1998","unstructured":"Culham JC, Brandt SA, Cavanagh P, Kanwisher NG, Dale AM, Tootell RBH (1998) Cortical fMRI activation produced by attentive tracking of moving targets. J Neurophysiol 80:2657\u20132670","journal-title":"J Neurophysiol"},{"key":"9092_CR8","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/01.wnl.0000210477.63851.d3","volume":"66","author":"LA Cysique","year":"2006","unstructured":"Cysique LA, Maruff P, Brew BJ (2006) Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology 66:1447\u20131450","journal-title":"Neurology"},{"key":"9092_CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1529-8027.2001.006001014.x","volume":"6","author":"MC Dalakas","year":"2001","unstructured":"Dalakas MC (2001) Peripheral neuropathy and antiretroviral drugs. J Peripher Nerv Syst 6:14\u201320","journal-title":"J Peripher Nerv Syst"},{"key":"9092_CR10","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1097\/00002030-200307040-00015","volume":"17","author":"GJ Dore","year":"2003","unstructured":"Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17:1539\u20131545","journal-title":"AIDS"},{"key":"9092_CR11","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S1053-8119(03)00232-5","volume":"19","author":"T Ernst","year":"2003","unstructured":"Ernst T, Chang L, Arnold S (2003) Increased glial markers predict increased working memory network activation in HIV patients. NeuroImage 19:1686\u20131693","journal-title":"NeuroImage"},{"key":"9092_CR12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1212\/01.WNL.0000031811.45569.B0","volume":"59","author":"T Ernst","year":"2002","unstructured":"Ernst T, Chang L, Jovicich J, Ames N, Arnold S (2002) Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology 59:1343\u20131349","journal-title":"Neurology"},{"key":"9092_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"9092_CR14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/nimg.1999.0484","volume":"10","author":"KJ Friston","year":"1999","unstructured":"Friston KJ, Holmes AP, Price CJ, Buchel C, Worsley KJ (1999) Multisubject fMRI studies and conjunction analyses. NeuroImage 10:385\u2013396","journal-title":"NeuroImage"},{"key":"9092_CR15","first-page":"214","volume":"1","author":"KJ Friston","year":"1994","unstructured":"Friston KJ, Worsley KJ, Frackowiak RSJ, Mazziotta JC, Evans AC (1994) Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1:214\u2013220","journal-title":"Hum Brain Mapp"},{"key":"9092_CR16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-4690-3-28","volume":"3","author":"M Ghafouri","year":"2006","unstructured":"Ghafouri M, Amini S, Khalili K, Sawaya BE (2006) HIV-1 associated dementia: symptoms and causes. Retrovirology 3:28","journal-title":"Retrovirology"},{"key":"9092_CR17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/01.qai.0000228790.40235.0c","volume":"42","author":"B Jiang","year":"2006","unstructured":"Jiang B, Hebert VY, Zavecz JH, Dugas TR (2006) Antiretrovirals induce direct endothelial dysfunction in vivo. J Acquir Immune Defic Syndr 42:391\u2013395","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9092_CR18","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1162\/089892901753294347","volume":"13","author":"J Jovicich","year":"2001","unstructured":"Jovicich J, Peters RJ, Koch C, Braun J, Chang L, Ernst T (2001) Brain areas specific for attentional load in a motion tracking task. J Cogn Neurosci 13:1048\u20131058","journal-title":"J Cogn Neurosci"},{"key":"9092_CR19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/aid.2006.22.386","volume":"22","author":"D Larussa","year":"2006","unstructured":"Larussa D, Lorenzini P, Cingolani A, Bossolasco S, Grisetti S, Bongiovanni M et al (2006) Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients. AIDS Res Hum Retrovir 22:386\u2013392","journal-title":"AIDS Res Hum Retrovir"},{"key":"9092_CR20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.20198","volume":"56","author":"SL Letendre","year":"2004","unstructured":"Letendre SL, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, Heaton RK et al (2004) Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol 56:416\u2013423","journal-title":"Ann Neurol"},{"key":"9092_CR21","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0730-725X(01)00460-X","volume":"19","author":"JM Levin","year":"2001","unstructured":"Levin JM, Frederick BB, Ross MH, Fox JF, vonRosenberg HL, Kaufman MJ et al (2001) Influence of baseline hematocrit and hemodilution on BOLD fMRI activation. Magn Reson Imaging 19:1055\u20131062","journal-title":"Magn Reson Imaging"},{"key":"9092_CR22","doi-asserted-by":"crossref","unstructured":"Lorenz MW, Stephan C, Harmjanz A, Staszewski S, Buehler A, Bickel M et al (2007) Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis (in press)","DOI":"10.1016\/j.atherosclerosis.2006.12.022"},{"key":"9092_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.expneurol.2006.09.010","volume":"204","author":"WO Opii","year":"2006","unstructured":"Opii WO, Sultana R, Abdul HM, Ansari MA, Nath A, Butterfield DA (2006) Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)-2\u2032,3\u2032-dideoxycytidine (ddC): Relevance to HIV-dementia. Exp Neurol 204:29\u201338","journal-title":"Exp Neurol"},{"key":"9092_CR24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1017\/S0317167100040154","volume":"22","author":"C Power","year":"1995","unstructured":"Power C, Johnson RT (1995) HIV-1 associated dementia: clinical features and pathogenesis. Can J Neurol Sci 22:92\u2013100","journal-title":"Can J Neurol Sci"},{"key":"9092_CR25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1212\/01.wnl.0000225183.74521.72","volume":"67","author":"N Sacktor","year":"2006","unstructured":"Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, et al (2006) Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67:311\u2013314","journal-title":"Neurology"},{"key":"9092_CR26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/13550280009006385","volume":"6","author":"N Sacktor","year":"2000","unstructured":"Sacktor N, Skolasky R, Lyles R, Esposito D, Selnes O, McArthur J (2000) Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J Neurovirol 6:84\u201388","journal-title":"J Neurovirol"},{"key":"9092_CR27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/13550280591002342","volume":"11","author":"BC Schweinsburg","year":"2005","unstructured":"Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez R, Brown GG, Ellis RJ et al (2005) Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol 11:356\u2013364","journal-title":"J Neurovirol"},{"issue":"Suppl 3","key":"9092_CR28","first-page":"101","volume":"10","author":"E Tarasow","year":"2004","unstructured":"Tarasow E, Wiercinska-Drapalo A, Jaroszewicz J, Orzechowska-Bobkiewicz A, Dzienis W, Prokopowicz D et al (2004) Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV-1H MRS evaluation. Med Sci Monit 10 Suppl 3:101\u2013106","journal-title":"Med Sci Monit"},{"key":"9092_CR29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.bjp.0702044","volume":"125","author":"SA Thomas","year":"1998","unstructured":"Thomas SA, Segal MB (1998) The transport of the anti-HIV drug, 2\u2032,3\u2032-didehydro-3\u2032-deoxythymidine (D4T), across the blood\u2013brain and blood\u2013cerebrospinal fluid barriers. Br J Pharmacol 125:49\u201354","journal-title":"Br J Pharmacol"},{"key":"9092_CR30","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.neuroimage.2004.07.065","volume":"23","author":"D Tomasi","year":"2004","unstructured":"Tomasi D, Ernst T, Caparelli EC, Chang L (2004) Practice-induced changes of brain function during visual attention: a parametric fMRI study at 4 Tesla. NeuroImage 23:1414\u20131421","journal-title":"NeuroImage"},{"key":"9092_CR31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(95)91184-7","volume":"345","author":"J Vion-Dury","year":"1995","unstructured":"Vion-Dury J, Nicoli F, Salvan A, Confort-Gouny S, Dhiver C, Cozzone P (1995) Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 345:60\u201361","journal-title":"Lancet"},{"key":"9092_CR32","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1006\/nimg.1996.0058","volume":"4","author":"RP Woods","year":"1996","unstructured":"Woods RP (1996) Modeling for intergroup comparisons of imaging data. NeuroImage 4:S84\u2013S94","journal-title":"NeuroImage"},{"key":"9092_CR33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/13803390490509565","volume":"26","author":"SP Woods","year":"2004","unstructured":"Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM et al (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26:759\u2013778","journal-title":"J Clin Exp Neuropsychol"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-007-9092-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-007-9092-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-007-9092-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T11:53:16Z","timestamp":1684065196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-007-9092-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,13]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9092"],"URL":"https:\/\/doi.org\/10.1007\/s11481-007-9092-0","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,13]]}}}